Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children
Clinical trial NCT01254175 · COMPLETED
Trial details
- NCT number
- NCT01254175
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.